Hyundai Motor India IPO Review: ₹27,870 Cr Mega Issue, Creta Moat, Valuation & Parent OFS
Hyundai Motor India brings the largest IPO in Indian stock market history at ₹27,870 Crore. Detailed breakdown of SUV leadership, export hub capabilities, EV roadmap, and valuation comparison with Maruti Suzuki and Tata Motors.
Published on · Verified Analysis
Editorial Key Takeaways
This analysis is based on official Draft Red Herring Prospectus (DRED) filings, historical peer valuation multiples, and exchange data. Figures are audited for institutional accuracy.
In This Article
Automotive heavyweight Hyundai Motor India Limited (HMIL) has written history with its ₹27,870 Crore mega Initial Public Offering — officially surpassing LIC to become India's largest public offering ever.
As India's second-largest passenger vehicle manufacturer with an undisputed leadership in the lucrative SUV segment, here is our full fundamental and valuation breakdown.
1. Issue Overview & Offering Structure
| Parameter | Issue Details |
|---|---|
| **Price Band** | ₹1,865 to ₹1,960 per share |
| **Lot Size** | 7 Equity Shares |
| **Minimum Retail Bid** | ₹13,720 (1 Lot at upper price band) |
| **Issue Size** | ₹27,870.16 Crore (100% OFS) |
| **Selling Shareholder** | Hyundai Motor Company (Korean Promoter) |
| **Pre-Issue Holding** | 100.0% |
| **Post-Issue Holding** | 82.5% |
| **Listing Date & Exchanges** | NSE & BSE Mainboard |
2. Market Position & SUV Moat
Hyundai has fundamentally shaped Indian passenger vehicle buying habits through its commanding SUV portfolio:
3. Financial Snapshot & Peer Benchmarking
| Financial Metric (₹ Crore) | FY24 | FY25 | FY26 (Est.) |
|---|---|---|---|
| **Total Revenue** | ₹69,829 | ₹77,500 | ₹86,200 |
| **EBITDA** | ₹9,150 | ₹10,460 | ₹12,100 |
| **EBITDA Margin (%)** | 13.1% | 13.5% | 14.0% |
| **Profit After Tax (PAT)** | ₹6,060 | ₹6,980 | ₹8,150 |
| **Return on Equity (ROE)** | 28.5% | 29.2% | 30.1% |
Peer Multiples Comparison
| Company | P/E Multiple | EBITDA Margin | ROE (%) | Market Cap (₹ Cr) |
|---|---|---|---|---|
| **Hyundai Motor India** | **26.2x** | **13.5%** | **29.2%** | **₹1,59,250** |
| **Maruti Suzuki** | 27.8x | 11.6% | 16.8% | ₹3,85,000 |
| **Tata Motors (Auto)** | 18.5x | 12.4% | 22.1% | ₹3,10,000 |
| **Mahindra & Mahindra** | 29.4x | 14.2% | 21.5% | ₹3,55,000 |
Hyundai delivers industry-leading capital return ratios (ROE ~29%) with superior EBITDA margins due to its heavy SUV sales mix.
4. EV Roadmap & Talegaon Capacity Expansion
To solidify its future pipeline, Hyundai has acquired the General Motors manufacturing facility in Talegaon, Maharashtra, which will expand HMIL's annual manufacturing capacity from 824,000 units to over 1.07 Million units.
On the electrification front, Hyundai is rolling out the localized Creta EV, backed by dedicated battery pack assembly lines in Chennai to benefit from FAME/PLI incentives.
5. Strengths vs Key Risks
Key Strengths
1. Unshakable Brand Equity: Top-of-mind brand loyalty in the ₹10L–₹25L family car segment.
2. Superior Profitability: Generates ₹87,000+ EBITDA per vehicle, well above mass-market competitors.
3. Robust Free Cash Flow: Generated ₹5,400+ Cr operating cash flow in FY25 with negative working capital.
Key Risks
1. 100% OFS Structure: Zero proceeds from the ₹27,870 Cr issue flow into the Indian entity for capex.
2. Royalty Payments: Royalty to Korean parent company fixed at 3.5% of revenue, impacting minority dividend flows.
3. Rising Royalty & EV Competition: Competition from Mahindra BEV and Tata.ev series.
6. Final Verdict & Strategy
Hyundai Motor India is an institutional compounder suited for core portfolio allocation. While the sheer issue size of ₹27,870 Crore may moderate listing-day explosive pops, it offers unmatched long-term wealth compounding potential. Verdict: Apply for Long-Term Portfolio Growth.
*Disclaimer: Purely educational research. Not SEBI investment advice.*
About IPOSathi Research
Primary Market Analyst & Senior Financial Journalist · IPO Latest Updates Daily
Our research desk specializes in reading SEBI Red Herring Prospectuses, institutional anchor allocations, and forensic balance sheet audits. Every report follows rigorous E-E-A-T research standards without promoter sponsorship.